Drug delivery by red blood cells: vascular carriers designed by mother nature.

Abstract:

IMPORTANCE OF THE FIELD:Vascular delivery of several classes of therapeutic agents may benefit from carriage by red blood cells (RBC), for example, drugs that require delivery into phagocytic cells and those that must act within the vascular lumen. The fact that several protocols of infusion of RBC-encapsulated drugs are now being explored in patients illustrates a high biomedical importance for the field. AREAS COVERED BY THIS REVIEW: Two strategies for RBC drug delivery are discussed: encapsulation into isolated RBC ex vivo followed by infusion in compatible recipients and coupling therapeutics to the surface of RBC. Studies of pharmacokinetics and effects in animal models and in human studies of diverse therapeutic enzymes, antibiotics and other drugs encapsulated in RBC are described and critically analyzed. Coupling to RBC surface of compounds regulating immune response and complement, affinity ligands, polyethylene glycol alleviating immune response to donor RBC and fibrinolytic plasminogen activators are described. Also described is a new, translation-prone approach for RBC drug delivery by injection of therapeutics conjugated with fragments of antibodies providing safe anchoring of cargoes to circulating RBC, without need for ex vivo modification and infusion of RBC. WHAT THE READER WILL GAIN:Readers will gain historical perspective, current status, challenges and perspectives of medical applications of RBC for drug delivery. TAKE HOME MESSAGE:RBC represent naturally designed carriers for intravascular drug delivery, characterized by unique longevity in the bloodstream, biocompatibility and safe physiological mechanisms for metabolism. New approaches for encapsulating drugs into RBC and coupling to RBC surface provide promising avenues for safe and widely useful improvement of drug delivery in the vascular system.

journal_name

Expert Opin Drug Deliv

authors

Muzykantov VR

doi

10.1517/17425241003610633

subject

Has Abstract

pub_date

2010-04-01 00:00:00

pages

403-27

issue

4

eissn

1742-5247

issn

1744-7593

journal_volume

7

pub_type

杂志文章,评审
  • New biomaterials for the sustained release of nitric oxide: past, present and future.

    abstract::Nitric oxide (NO), the 1992 'Molecule of the Year', is the focus of immense medical and scientific exploration. Interest in NO has grown exponentially since the initial and relatively recent discovery that NO is the long sought after endothelial relaxing factor. There is intense research that is continuing to expose t...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903196743

    authors: Friedman A,Friedman J

    更新日期:2009-10-01 00:00:00

  • Epidermal delivery of protein and DNA vaccines.

    abstract::Targeting vaccines to the skin epidermis results in the activation of an immune inductive site that is rich in antigen-presenting cells. The superficial location of the skin makes it accessible to vaccine delivery. However, it is difficult to access the epidermis using needle and syringe delivery, and vaccine antigens...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2.2.227

    authors: Dean HJ

    更新日期:2005-03-01 00:00:00

  • The microfabricated electrokinetic pump: a potential promising drug delivery technique.

    abstract::Directly delivering liquid using direct current power was a dream for 40 years. Now, the electrokinetic pump can accomplish it. This review reports recent developments in microfabricated electrokinetic pump technologies and their applications, and also discusses the electrophoresis pump and elctroosmotic pump, as well...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.4.2.119

    authors: Chen L,Choo J,Yan B

    更新日期:2007-03-01 00:00:00

  • Endothelial nanomedicine for the treatment of pulmonary disease.

    abstract:INTRODUCTION:Even though pulmonary diseases are among the leading causes of morbidity and mortality in the world, exceedingly few life-prolonging therapies have been developed for these maladies. Relief may finally come from nanomedicine and targeted drug delivery. AREAS COVERED:Here, we focus on four conditions for w...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.961418

    authors: Brenner JS,Greineder C,Shuvaev V,Muzykantov V

    更新日期:2015-02-01 00:00:00

  • The role of intracochlear drug delivery devices in the management of inner ear disease.

    abstract:INTRODUCTION:Diseases of the inner ear include those of the auditory and vestibular systems, and frequently result in disabling hearing loss or vertigo. Despite a rapidly expanding pipeline of potential cochlear therapeutics, the inner ear remains a challenging organ for targeted drug delivery, and new technologies are...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.974548

    authors: Ayoob AM,Borenstein JT

    更新日期:2015-03-01 00:00:00

  • Transdermal delivery of calcium channel blockers for hypertension.

    abstract:INTRODUCTION:Calcium channel blockers are a very important class of antihypertensive drugs. Most calcium channel blockers (CCBs) exhibiting low oral bioavailability are required to be taken more than once a day due to their short half-lives which result in poor patient compliance. There is an ineluctable requirement fo...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.783562

    authors: Ahad A,Al-Jenoobi FI,Al-Mohizea AM,Aqil M,Kohli K

    更新日期:2013-08-01 00:00:00

  • Drug delivery strategies for therapy of visceral leishmaniasis.

    abstract:IMPORTANCE OF THE FIELD:Visceral leishmaniasis (VL) is the most overwhelming type of leishmaniasis associated with the poverty of developing countries and usually mortal if untreated. Most of the conventionally used dosage forms offer us the shortcomings of toxic side effects and emergence of drug resistance. Several e...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903548232

    authors: Gupta S,Pal A,Vyas SP

    更新日期:2010-03-01 00:00:00

  • Role of in vitro release models in formulation development and quality control of parenteral depots.

    abstract::This review article provides an assessment of advantages/limitations of the use of current in vitro release models to predict in vivo performance of parenteral sustained release products (injectable depots). As highlighted, key characteristics influencing the in vivo drug fate may vary with the route of administration...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903307431

    authors: Larsen C,Larsen SW,Jensen H,Yaghmur A,Ostergaard J

    更新日期:2009-12-01 00:00:00

  • Controlled release of therapeutics using interpenetrating polymeric networks.

    abstract:INTRODUCTION:The ever-increasing developments in pharmaceutical formulations have led to the widespread use of biodegradable polymers in various forms and configurations. In particular, interpenetrating network (IPN) and semi-IPN polymer structures that are capable of releasing drugs in a controlled manner have gained ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.974871

    authors: Aminabhavi TM,Nadagouda MN,More UA,Joshi SD,Kulkarni VH,Noolvi MN,Kulkarni PV

    更新日期:2015-04-01 00:00:00

  • Delivery of therapeutic RNA-cleaving oligodeoxyribonucleotides (deoxyribozymes): from cell culture studies to clinical trials.

    abstract:INTRODUCTION:Development of efficient in vivo delivery systems remains a major challenge en route to clinical application of antisense technology, including RNA-cleaving molecules such as deoxyribozymes (DNAzymes). The mechanisms of oligonucleotide uptake and trafficking are clearly dependent on cell type and the type ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2017.1266326

    authors: Fokina AA,Chelobanov BP,Fujii M,Stetsenko DA

    更新日期:2017-09-01 00:00:00

  • Drug delivery using multifunctional dendrimers and hyperbranched polymers.

    abstract:IMPORTANCE OF THE FIELD:The review presents the design strategy and synthesis of multifunctional dendrimers and hyperbranched polymers with the objective to develop effective drug delivery systems. AREAS COVERED IN THIS REVIEW:Well-characterized, commercially available dendritic polymers were subjected to functionaliz...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2010.534981

    authors: Paleos CM,Tsiourvas D,Sideratou Z,Tziveleka LA

    更新日期:2010-12-01 00:00:00

  • Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics.

    abstract:INTRODUCTION:Superparamagnetic iron oxide nanoparticle (SPION)-based carrier systems have many advantages over other nanoparticle-based systems. They are biocompatible, biodegradable, facilely tunable and superparamagnetic and thus controllable by an external magnetic field. These attributes enable their broad biomedic...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.747507

    authors: Mok H,Zhang M

    更新日期:2013-01-01 00:00:00

  • Delivery methods for drugs used in the treatment of overactive bladder.

    abstract:INTRODUCTION:Overactive bladder affects a significant portion of the population and results in prescribing of numerous medications for its treatment. Traditional drug delivery systems used in therapy are associated with multiple commonly reported side effects. Adherence rates with use of these medications are low. It i...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2016.1130033

    authors: Scott K,Dmochowski RR,Padmanabhan P

    更新日期:2016-01-01 00:00:00

  • Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors.

    abstract:INTRODUCTION:Transportation of the nutrients and other substances from the blood to the brain is selectively controlled by the brain capillary endothelial cells that form a restrictive barrier, so-called blood-brain barrier (BBB). Currently, there is no unimpeachable approach to overcome the BBB obstructiveness because...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1614911

    authors: Jafari B,Pourseif MM,Barar J,Rafi MA,Omidi Y

    更新日期:2019-06-01 00:00:00

  • Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility.

    abstract:INTRODUCTION:Drug release and oral absorption of drugs with pH-dependent solubility are influenced by the conditions in the gastrointestinal tract. In some cases, poor oral absorption has been observed for these drugs, causing insufficient drug efficacy. The pH-modification of a formulation could be a promising approac...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.881798

    authors: Taniguchi C,Kawabata Y,Wada K,Yamada S,Onoue S

    更新日期:2014-04-01 00:00:00

  • Carbon nanotubes for the delivery of therapeutic molecules.

    abstract::Functionalised carbon nanotubes (f-CNTs) are emerging as new tools in the field of nanobiotechnology and nanomedicine. This is because they can be easily manipulated and modified by encapsulation with biopolymers or by covalent linking of solubilising groups to the external walls and tips. The possibility of incorpora...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.1.1.57

    authors: Bianco A

    更新日期:2004-11-01 00:00:00

  • Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.

    abstract::The introduction of insulin pens has helped improve adherence in Type 1 or 2 diabetes, and reduce inaccurate dosing, fear of injection, and social embarrassment associated with vial and syringe. This report presents the published evidence base for the accuracy, patient preference and economic evaluation of one prefill...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.8.915

    authors: Pfützner A,Asakura T,Sommavilla B,Lee W

    更新日期:2008-08-01 00:00:00

  • Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery.

    abstract:INTRODUCTION:Neurodegenerative diseases (NDs) represent a group of different clinical entities that, despite the specific primary etiologies, share a common signature in terms of a general mitochondrial dysfunction with consequent oxidative stress accumulation. As these two events occur early during neurodegenerative p...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1218461

    authors: Pezzini I,Mattoli V,Ciofani G

    更新日期:2017-04-01 00:00:00

  • Chitosan-based gastroretentive floating drug delivery technology: an updated review.

    abstract:INTRODUCTION:Gastroretentive floating drug delivery systems have emerged as efficient approaches for enhancing the bioavailability and controlled delivery of various therapeutic agents. Significant advancements exploiting chitosan have been made worldwide, in order to investigate these systems according to patient requ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.673581

    authors: Pahwa R,Saini N,Kumar V,Kohli K

    更新日期:2012-05-01 00:00:00

  • Recent advances in polymeric microspheres for parenteral drug delivery--part 1.

    abstract:INTRODUCTION:Polymeric microspheres have been established as a valuable parenteral drug delivery system for sustained release of therapeutic agents via subcutaneous or intramuscular injection. AREAS COVERED:Biodegradable polymers which are either synthetic or from natural sources are reviewed with respect to recent ad...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.709844

    authors: Mao S,Guo C,Shi Y,Li LC

    更新日期:2012-09-01 00:00:00

  • Focused ultrasound for blood-brain disruption and delivery of therapeutic molecules into the brain.

    abstract::Noninvasive, transient and local image-guided blood-brain barrier disruption can be accomplished using focused ultrasound exposure with intravascular injection of preformed microbubbles. MRI-guided blood-brain barrier disruption has been demonstrated and has been shown to heal in within a few hours after exposure. The...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.4.1.27

    authors: Hynynen K

    更新日期:2007-01-01 00:00:00

  • Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.

    abstract::Many agents used to treat cancer are toxic to normal tissues. Thus, treatments delivering drug specifically to tumour, while minimising exposure to normal tissue, may be advantageous over non-targeted treatments. The exquisite specificity of the immune system has been used successfully to help develop targeted antican...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.1.87

    authors: Brumlik MJ,Daniel BJ,Waehler R,Curiel DT,Giles FJ,Curiel TJ

    更新日期:2008-01-01 00:00:00

  • A pen device for injection of recombinant human growth hormone: a European usability engineering study.

    abstract:OBJECTIVE:The Aluetta™ reusable pen device and instructions for use (IFU) for growth hormone (r-hGH; Saizen®, Merck KGaA, Darmstadt, Germany) administration were tested for Human-Factors Usability, to ensure it could be used safely and effectively by the intended users in the intended use environment. RESEARCH DESIGN ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2020.1774549

    authors: Cachemaille A,Warren SE,Moss S

    更新日期:2020-07-01 00:00:00

  • Modulating antibody pharmacokinetics using hydrophilic polymers.

    abstract:INTRODUCTION:The use of hydrophilic polymers as a substitute for the Fc-domain in immuno- or non-immuno-based binding proteins is accelerating. Chemical PEGylation has led the way and is still the most advanced and clinically-approved approach. Hydrophilic polymers act by maintaining a flexible conformation and hydroge...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2011.602399

    authors: Chen C,Constantinou A,Deonarain M

    更新日期:2011-09-01 00:00:00

  • Stimuli-responsive polymers for antimicrobial therapy: drug targeting, contact-killing surfaces and competitive release.

    abstract:INTRODUCTION:Polymers can be designed to modify their features as a function of the level and nature of the surrounding microorganisms. Such responsive polymers can endow drug delivery systems and drug-medical device combination products with improved performance against intracellular infections and biofilms. AREAS CO...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1178719

    authors: Alvarez-Lorenzo C,Garcia-Gonzalez CA,Bucio E,Concheiro A

    更新日期:2016-08-01 00:00:00

  • Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons.

    abstract:INTRODUCTION:Simvastatin (SV) is a drug from the statin class, currently used orally as an anti-cholesterolemic drug. It inhibits the 3-hydroxy-3-methyl-glutaryl-Coenzyme A (HMG-CoA) reductase to reduce cholesterol synthesis. Recently, it has been found that SV also has several other protective pharmacological actions ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1193150

    authors: Tulbah AS,Ong HX,Colombo P,Young PM,Traini D

    更新日期:2016-10-01 00:00:00

  • Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.

    abstract:INTRODUCTION:Many drug candidates with high therapeutic efficacy have low water solubility, which limits the administration and transport across physiological barriers, for example, the tumor tissue barrier. Therefore, strategies are needed to permeabilize the physiological barriers safely so that hydrophobic drugs may...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.1021681

    authors: Wang G,Wang J,Wu W,Tony To SS,Zhao H,Wang J

    更新日期:2015-01-01 00:00:00

  • Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier.

    abstract::Introduction: Current therapies of neurodegenerative or neurometabolic diseases are, to a large extent, hampered by the inability of drugs to cross the blood-brain barrier (BBB). This very tight barrier severely restricts the entrance of molecules from the blood into the brain, especially macromolecular substances (i....

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2020.1698544

    authors: Tosi G,Duskey JT,Kreuter J

    更新日期:2020-01-01 00:00:00

  • Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.

    abstract:INTRODUCTION:Interest in mesoporous silica nanoparticles for drug delivery has resulted in a good understanding of the impact of size and surface chemistry of these nanoparticles on their performance as drug carriers. Shape has emerged as an additional factor that can have a significant effect on delivery efficacy. Rod...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2018.1517748

    authors: Cong VT,Gaus K,Tilley RD,Gooding JJ

    更新日期:2018-09-01 00:00:00

  • Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.

    abstract:BACKGROUND:Efficient and minimally invasive vector systems appear to be the most appropriate for both gene therapy and drug delivery. Numerous viral and non-viral vectors have been developed. Each vector has its own advantages and limitations. OBJECTIVE:New vectors have been required for overcoming the limitations of ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.2.221

    authors: Kaneda Y

    更新日期:2008-02-01 00:00:00